Sudarshan Pharma Q2 Profit Surges 86% to Rs 7.78 Crore; Revenue Jumps 28% as Margins Improve

A key highlight of the quarterly performance was the significant improvement in profitability, with net profit growing more than three times faster than revenue in percentage terms. The company’s net profit margin expanded to 3.6% from 2.5% a year earlier, indicating improved earnings efficiency.

bolt Latest News Updates for You

Rising Medical Costs Shape Young Adults’ Approach to Health Insurance vs Critical Illness Cover

NEW

Fiberweb India Limited Q2 FY27 Total Income Surges 209.36% QoQ to ₹30.99 Cr; EBITDA Rises 76.77% & Net Profit Jumps 366.02%

Gold Falls Below $4,000; Indian Equities End Weak Week With Cautious Outlook: Aetram Group

The latest results demonstrate strengthening operational performance, supported by higher revenue generation and better profit conversion. The company recorded an additional ₹48.10 crore in quarterly revenue, while net profit increased by ₹3.60 crore compared with the corresponding period last year.

The improved financial performance could attract investor attention, particularly as the company continues to expand its business operations and strengthen its presence in the pharmaceutical sector.

Also Read

Fiberweb India Limited Q2 FY27 Total Income Surges 209.36% QoQ to ₹30.99 Cr; EBITDA Rises 76.77% & Net Business

Going forward, sustained revenue growth, improving margins and earnings consistency will remain important factors for investors tracking Sudarshan Pharma’s financial performance.